Thyroid dysfunction in non-small cell lung cancer patients treated with epidermal growth factor receptor and anaplastic lymphoma kinase inhibitors: Results of a prospective cohort-Reference-Cited by-同舟云学术

Thyroid dysfunction in non-small cell lung cancer patients treated with epidermal growth factor receptor and anaplastic lymphoma kinase inhibitors: Results of a prospective cohort

Published:2021-01 Issue: Volume:151 Page:16-19
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Soni Swati,Rastogi Ashu,Prasad Kuruswamy T.,Behera Digambar,Singh Navneet

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference16 articles.

1. Endocrine side-effects of anti-cancer drugs: thyroid effects of tyrosine kinase inhibitors;Illouz;Eur. J. Endocrinol.,2014

2. Erlotinib-associated exacerbation of hypothyroidism with pericardial tamponade;Kastoon;Endocr. Pract.,2012

3. Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

4. Relationship of epidermal growth factor receptor activating mutations with histologic subtyping according to International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society 2011 adenocarcinoma classification and their impact on overall survival

5. Comorbidity assessment using charlson comorbidity index and simplified comorbidity score and its association with clinical outcomes during first-line chemotherapy for lung Cancer;Singh;Clin. Lung Cancer,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine kinase inhibitor–induced hypothyroidism: mechanism and clinical implications;European Journal of Clinical Pharmacology;2024-03-14

2. Clinical Characters and Influence Factors of Immune Checkpoint Inhibitor-related Thyroid Dysfunction;The Journal of Clinical Endocrinology & Metabolism;2023-05-15

3. Thyroid dysfunction with atezolizumab plus bevacizumab after lenvatinib in hepatocellular carcinoma: A case series;SAGE Open Medical Case Reports;2023-01

4. Combination of Novel Therapies and New Attempts in Anaplastic Thyroid Cancer;Technology in Cancer Research & Treatment;2023-01

5. Research Progress of Immunotherapy for Gastric Cancer;Technology in Cancer Research & Treatment;2023-01